1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
66F02BA878787CAE885256D340001CBD8
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-communicating-pharmaceutical-clinical-trial-results?opendocument
18
19opendocument
2018.97.14.85
21
22
23
24/bestp/domrep.nsf
25DB




» Products & Services » » Clinical Operations » Communicating Clinical Trial Results

Best Practices in Communicating Clinical Trial Results: Overview & Lessons Learned

DB Image

ID: 4433


Features:

Summary Matrix


Words: 3,448


Published: Pre-2020


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • BROWSE SELECTED PAGES
  • SPECIAL OFFER
This 10-page document provides a quick overview of the project background and focus as well as seven key findings and the top three lessons learned by executives at leading pharmaceutical companies on communicating clinical trial results. Successful communication of clinical trial results links benefits shown in the study to key products, allowing companies to gain significant advantage in the market. This research originated from Best Practices, LLC's consulting services.

Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
Abbott Laboratories; Sanofi-aventis; AstraZeneca; Bristol-Myers Squibb; Eli Lilly; GlaxoSmithKline; Janssen; Merck; Pharmacia; Novartis; Schering-Plough

Browse Selected Pages
Click on an image below to see the full PDF version


Cover Page

Participating Companies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.